Workgroup Members Attending

State of California:

• Tomas Aragon, MD, Dr.PH, Director California Department of Public Health and State Health Officer; 
• Eric Goosby, MD, Distinguished Professor of Medicine and Director of the Center for Global Health Delivery, University of California, San Francisco; 
• Nicola Klein, MD, Director, Kaiser Permanente Vaccine Study Center; 
• Rodney Hood, MD, Trustee, Alliance Healthcare Foundation; 
• Grace Lee, MD, Professor of Pediatrics and Associate Chief Medical Officer for Practice Innovation, Stanford Children’s Health; 
• Bonnie Maldonado, MD, Professor and Chief of the Division of Infectious Diseases, Department of Pediatrics, Stanford Medicine; 
• Arthur Reingold, MD, School of Public Health Division Head of Epidemiology and Biostatistics, University of California, Berkeley; 
• Mark Sawyer, MD, Infectious Disease Specialist, Rady Children's Hospital; 
• Rob Schechter, MD, Chief, California Department of Public Health, Immunization Branch; 
• Peter Szilagyi, MD, Professor and Vice Chair for Clinical Research, Department of Pediatrics and Mattel Children's Hospital; 
• Matt Zahn, MD, Medical Director, Communicable Disease Control Division, Orange County Health Care Agency.

State of Washington:

• John Dunn, MD, Medical Director for Preventive Care and Head of Immunization Program, Kaiser Permanente Washington
  
• Edgar K. Marcuse, MD, MPH, FPIDS, Emeritus Professor, Pediatrics, University of Washington

State of Nevada:

• Ihsan Azzam, MD, Chief Medical Officer, Division of Public and Behavioral Health; 
• Kyle Devine, Bureau Chief for the Bureau of Child, Family, and Community Wellness (CFCW); 
• Kristy Zigenis, Contracted COVID-19 Vaccine Program Manager, CFCW

State of Oregon:

• Laura Byerly, MD, Chief Medical Officer, Virginia Garcia Health Center; 
• Tony Lapiz, MPH, Health Policy Advisor, Office of Governor Kate Brown

Workgroup Members Not Attending

• Oliver Brooks, MD, CMO, Watts Health Care; 
• Louis Picker, MD, Associate Director of Oregon Health & Science University’s Vaccine and Gene Therapy Institute.
  

Consultant

• Bobbie Wunsch, Founder and Partner, Pacific Health Consulting Group
  

Welcome and Setting Stage for Today’s Discussion Topics

Arthur Reingold, MD, Chair

Dr. Reingold welcomed members of the Western States Scientific Safety Review Workgroup.
The CDC Advisory Committee on Immunization Practices (ACIP) met today, April 20, 2022. ACIP discussed updates and reviewed COVID-19 vaccine safety data and vaccine effectiveness. The ACIP discussion focused on the benefit-risk of a second COVID-19 booster dose (4th total dose) for adults aged 50 years and older and aged 12 years and older who are immunocompromised. There was also discussion of the overall purpose of COVID-19 vaccinations. There is no new information about the timing for an Emergency Use Authorization (EUA) of COVID-19 vaccine for children age 5 years and younger. ACIP did not vote on any recommendations at the meeting and Dr. Pan suggested there is no expectation of a statement from the Workgroup.

Workgroup Discussion

Arthur Reingold, MD, Chair
Grace Lee, MD, ACIP Chair and Western States Members

Timing of Western States Statement and Next Steps

Arthur Reingold, MD, Chair
There will not be a statement issued following this meeting. Exact timing for the next meeting is not known. There are a series of items ready to go to FDA and it is likely there may be a continuing series of meetings over the summer.